Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: Waterbury, Connecticut 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
PHASE3INTERVENTIONAL Escondido, California +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Glendale, Arizona +4 more
RECRUITING
A Novel Digital Tool Clinicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
NAINTERVENTIONAL Farmington, Connecticut +2 more
RECRUITING
Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
NAINTERVENTIONAL New Haven, Connecticut
RECRUITING
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
PHASE2INTERVENTIONAL New Haven, Connecticut
RECRUITING
Craving Network Neurofeedback
NAINTERVENTIONAL New Haven, Connecticut
RECRUITING
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
New Mechanisms of Obesity
NAINTERVENTIONAL New Haven, Connecticut
RECRUITING
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Pain and Weight Treatment: Development and Trial of PAW
NAINTERVENTIONAL Hartford, Connecticut
RECRUITING
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
NAINTERVENTIONAL Hartford, Connecticut
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type